What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It means replacing hormones (usually estrogen, progesterone, and/or testosterone) with preparations that are chemically identical to the hormones the body makes. You might consider it if you have symptoms of hormone deficiency (most commonly menopausal or andropause symptoms), but whether you “need” it depends on your symptoms, medical history, labs, and risks — so discuss it with a clinician.

What BHRT is (brief)

• “Bioidentical” means the hormone molecule is the same as human hormones (for example, 17β‑estradiol rather than conjugated equine estrogens).
• BHRT can be prescribed as FDA‑approved products (tablets, patches, gels, vaginal rings, creams) or as custom‑compounded preparations made by compounding pharmacies.
• Routes: transdermal (patch/gel), oral, vaginal/local, and sometimes injectable.

Who commonly considers BHRT

• Women with moderate–severe menopausal symptoms: hot flashes/night sweats, vaginal dryness and painful intercourse, sleep disturbance, mood changes.
• Perimenopausal women with irregular cycles and bothersome symptoms.
• Men with clinically confirmed low testosterone and symptoms such as low libido, fatigue, low muscle mass (after proper testing).
• People with documented hormone deficiencies causing functional problems (on a case‑by‑case basis).

How you and your clinician decide if you need it

1. Review symptoms: keep a symptom diary (hot flashes, night sweats, vaginal symptoms, libido, mood, sleep, energy).
2. Medical history and risks: personal/family history of breast cancer, blood clots, stroke, heart disease, liver disease, or uncontrolled hypertension affect the decision.
3. Baseline tests commonly ordered
   • Women: serum FSH and estradiol can help for perimenopause/menopause, but symptoms are often enough for treatment decisions. Check TSH (thyroid), lipids, fasting glucose; consider bone density (DEXA) if appropriate.
   • Men: morning total testosterone (and free testosterone if needed), LH, prolactin; repeat test to confirm low values.
   • Labs are usually done with standard blood draws (LabCorp, Quest). Saliva/urine hormone panels are used by some clinics but are less reliable for dosing decisions.
4. Discuss benefits and risks, start lowest effective dose and preferred route (transdermal estrogen often has lower clot risk than oral), and plan follow‑up.
5. Reassess symptoms and monitor labs/health markers periodically.

Benefits and risks

• Benefits: effective for relieving menopausal vasomotor symptoms and genitourinary symptoms; improves quality of life and may help bone density. Testosterone can improve libido and energy in men and sometimes in women (off‑label).
• Risks: some increased risks for blood clots, stroke, and — depending on regimen and duration — breast cancer risk. The long‑term safety advantage of compounded “bioidentical” over conventional HRT is not proven. Large studies used non‑bioidentical formulations, so claims that compounded BHRT is safer are not established.

FDA‑approved products I commonly see recommended (safer first option)

• Estradiol patches: Vivelle‑Dot, Climara — transdermal, steady dosing, lower VTE risk than oral.
• Oral estradiol: Estrace (micronized estradiol) — bioidentical molecule, FDA‑approved.
• Vaginal/local estrogen: Vagifem (tablet), Estring (ring) — for vaginal dryness/urogenital symptoms with lower systemic exposure.
• Micronized progesterone: Prometrium — FDA‑approved bioidentical progesterone for women with a uterus to protect endometrium.
• Testosterone (men): AndroGel, Testim — FDA‑approved testosterone gels for men. (Testosterone for women is commonly off‑label and should be managed carefully.)

Compounded BHRT

• Pros: customized doses/combined formulations, topical creams.
• Cons: less regulation, variable potency/consistency, limited safety/outcome data. If you use compounded hormones, choose a reputable, USP‑verified or state‑licensed compounding pharmacy (ask about quality testing).

Who should NOT use BHRT (common contraindications)

• Current or past estrogen‑sensitive breast cancer (usually), active blood clots or history of venous thromboembolism, untreated endometrial hyperplasia, active liver disease, pregnancy. Individual cases require specialist input.

What to do next

• See your primary care doctor, gynecologist, or an endocrinologist/menopause specialist. Ask about:
  • Which symptoms are likely hormone‑related,
  • Baseline tests to order,
  • FDA‑approved vs compounded options,
  • Risks for your personal health profile, and monitoring plan.
• Trusted resources: North American Menopause Society (NAMS) and Endocrine Society guidelines are good, evidence‑based references.

If you’d like, tell me your age, sex, and main symptoms (and any relevant medical history), and I can suggest what tests to ask for and which specialists to consult.